Compare CDNA & KODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | KODK |
|---|---|---|
| Founded | 1998 | 1880 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 834.8M |
| IPO Year | 2014 | N/A |
| Metric | CDNA | KODK |
|---|---|---|
| Price | $19.16 | $8.40 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $26.67 | N/A |
| AVG Volume (30 Days) | 750.2K | ★ 1.4M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.22 | N/A |
| Revenue | $357,998,000.00 | ★ $1,045,000,000.00 |
| Revenue This Year | $14.11 | N/A |
| Revenue Next Year | $11.75 | N/A |
| P/E Ratio | $15.51 | ★ N/A |
| Revenue Growth | ★ 14.46 | N/A |
| 52 Week Low | $10.96 | $4.93 |
| 52 Week High | $25.95 | $9.96 |
| Indicator | CDNA | KODK |
|---|---|---|
| Relative Strength Index (RSI) | 54.20 | 50.87 |
| Support Level | $19.01 | $8.50 |
| Resistance Level | $20.61 | $9.13 |
| Average True Range (ATR) | 0.71 | 0.36 |
| MACD | -0.22 | -0.09 |
| Stochastic Oscillator | 18.43 | 32.14 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.